Cash Equivalents and Marketable Securities

3 Months Ended

Mar. 31, 2020

Cash Equivalents and Marketable Securities

Cash Equivalents and Marketable Securities

Note 5. Cash Equivalents and Marketable Securities

Cash Equivalents and Marketable Securities

Cash equivalents and marketable securities consisted of the following (in thousands):

	March 31, 2020
	Amortized		Gross Unrealized
	Cost		Gains		Losses		Fair Value
Money market funds	$	45,644	$	—	$	—	$	45,644
Commercial paper		39,576		3		(16)		39,563
Corporate debt securities		13,289		2		(3)		13,288
U.S. Treasury and agency securities		17,508		24		(1)		17,531
Total cash equivalents and marketable securities	$	116,017	$	29	$	(20)	$	116,026
Classified as:
Cash equivalents							$	58,728
Marketable securities								57,298
Total cash equivalents and marketable securities							$	116,026

	December 31, 2019
	Amortized		Gross Unrealized
	Cost		Gains		Losses		Fair Value
Money market funds	$	12,964	$	—	$	—	$	12,964
Commercial paper		44,284		2		(4)		44,282
Corporate debt securities		33,653		11		(2)		33,662
U.S. Treasury and agency securities		40,798		14		(2)		40,810
Total cash equivalents and marketable securities	$	131,699	$	27	$	(8)	$	131,718
Classified as:
Cash equivalents							$	31,707
Marketable securities								100,011
Total cash equivalents and marketable securities							$	131,718

All marketable securities held as of March 31, 2020 and December 31, 2019 had contractual maturities of less than one year. There were no material realized gains or realized losses on marketable securities for the periods presented. The Company has not experienced any material credit losses on its investments.